Ticker HubNasdaq

CMND

Clearmind Medicine Inc. Common Shares

Latest price

$6.04-2.88%

As of Nov 2, 2026, 10:33 AM EST · Market data by Massive

Market cap

$3.2M

Volume

716

Previous close

$6.22

Day range

$6.01 – $6.04

Listed

Aug 10, 2021

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $6.35Latest interval $6.14

Newsroom

Latest CMND coverage

NewsNov 23, 2022

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial

Clearmind Medicine Inc. announced the initiation of clinical batches of production of its novel psychedelic-derived drug candidate, the MEAI- based molecule- CMND-100.

CMND

Company overview

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Employees: 2
CIK: 0001892500

Company website View advanced chart